Skip to main content
. 2021 Mar 1;41(5):952–960. doi: 10.1038/s41372-021-01001-0

Table 1.

Participant characteristicsa that had viral symptoms (M1–M5) and without symptoms (M5–M9), who donated 4 consecutive human milk samples (once per month) during the COVID-19 pandemic from March 2020 to June 2020.

Mothers Viral symptoms Infant sex Postpartum time (mo) Mother’s age vaccine during pregnancy
Mother-1, M1 Viral infection in end-February 2020 flu-like symptoms (fever and headaches) for 1.5 wks Female 5 29 None
Mother-2, M2 Fever, chills, body aches, congestion, cough 2/28/2020 to 03/14/2020 Female 3 32 Tdap
Mother-2, M3 Cold symptoms from 02/27/20 to 03/05/20; coughing, runny nose, and fever. Male 5 32 None
Mother-4, M4 Viral infection from 03/04/20 to 03/13/20. Symptoms: sneezing, headache, fever, vomiting Female 5.5 23 Tdap and Rhogam
Mother-5, M5 Sinus infection—headache, congested, sore throat—mid-March 2020 for 2 weeks Male 4 31 Tdap
Mother-6, M6 None Male 6 35 Influenza and Tdap
Mother-7, M7 None Male 3 31 Influenza
Mother-8, M8 None Male 3 21 None
Mother-9, M9 None Female 3 35 Influenza and Tdap

aWomen did not have a medical history, medication, and systematic diseases.